EMERON.IO / GLOBAL GOV-TECH / EST. 2013
12
Supervisory modules
~6,400
Facilities modelled
~88,000
Practitioners on the register
5yr
Synthetic regulatory history
§ 01 / THE SCENARIO

"NHRA-Astoria" and the regulated population.

The National Health Regulatory Authority of Astoria is a fictional unitary regulator covering facility licensing, professional registration, pharmaceutical authorization, and medical-device oversight. Approximately 6,400 facilities are licensed (hospitals, clinics, pharmacies, diagnostic centres, dental practices, mortuaries). Approximately 88,000 practitioners are on the register (physicians, nurses, pharmacists, allied health). Approximately 14,000 drug marketing authorizations are active. The authority has 320 staff, including 120 inspectors.

§ 02 / SUPERVISORY MODULES CONFIGURED

Twelve workflows, one supervisory record per entity.

H-01
Facility licensing
New, variation, renewal, surrender. Conditional licences. Class-specific requirements.
H-02
Practitioner registration
Initial registration, scope of practice, CPD tracking, restoration after lapse.
H-03
Drug marketing authorization
New chemical entities, generics, biologics. Variation. Renewal. Withdrawal.
H-04
Medical device registration
Class I through IV. Conformity assessment. Post-market surveillance.
H-05
Pharmacovigilance
Adverse drug reaction reporting. Signal detection. Safety alerts to the field.
H-06
Inspections
Annual programme. Triggered (complaint, ADR, intelligence). Working papers and findings ledger.
H-07
Complaints & whistleblowing
From public, from health workers, from peer practitioners. Triage and routing.
H-08
Enforcement & sanctions
Suspension, deregistration, fines, public notices. Hearings. Appeals.
H-09
Public registers
Licensed facilities, registered practitioners, authorized drugs. Real-time publication.
H-10
Fees & levies
Application fees, annual levies, fine recovery.
H-11
International cooperation
WHO drug alerts, regional regulatory harmonization, mutual recognition.
H-12
Rulebook management
Versioned regulatory text. Every enforcement decision links to the rulebook version in force at the time.
§ 03 / WHAT THE DEMONSTRATION CAN SHOW

Five scenarios walked through end-to-end.

  1. SC1

    From complaint to enforcement

    A complaint about a private hospital is received. Triage, intelligence check, triggered inspection, findings, enforcement notice. Five-day walkthrough.

  2. SC2

    Drug marketing authorization

    A generic drug application: file completeness, scientific review, GMP inspection of the manufacturing facility (in a foreign jurisdiction, via cooperation), authorization, publication.

  3. SC3

    Practitioner discipline

    A peer complaint against a physician. Privileged investigation. Hearing. Sanction. Public register update. Appeal.

  4. SC4

    Pharmacovigilance signal

    An adverse drug reaction pattern triggers a signal. Cluster analysis. Field communication. Risk-management plan update. Restriction.

  5. SC5

    Rulebook change

    A revised standard for a class of medical devices is published. Effective-date logic applies to in-flight applications. Re-assessment workflow for already-authorized devices.

§ 04 / WHAT MAKES THIS HARD

Three things generic platforms cannot do.

Time-versioned rulebook
A drug authorized in 2024 under one standard, reviewed in 2030 under a revised standard, must show against which standard each decision was made. The platform binds every supervisory record to the rulebook version in force.
Privileged investigations
A disciplinary investigation against a practitioner must be sequestered from supervisors who happen to know the practitioner socially. Access control is at the case level, not the role level.
Public record at the moment of decision
A drug withdrawal must appear on the public register the moment the decision is signed. The publication step is part of the workflow, not a separate publishing system.
DISCLOSURE

NHRA-Astoria does not exist. The 6,400 facilities, 88,000 practitioners, and 14,000 drug authorizations are synthetic data. The supervisory record model, modules, workflows, and configuration are the real product. The rulebook used in the demonstration is a fictional composite drawn from publicly-available health regulatory frameworks.

Book the regulator walkthrough.

Delivered by a principal engineer plus a former senior regulator advising on the supervisory stack. Five scenarios in three hours. Onsite or remote. The session also covers what would change for a financial supervisor, a telecom regulator, or an energy authority.